Equities

United Health Products Inc

UEEC:PKC

United Health Products Inc

Actions
  • Price (USD)0.1775
  • Today's Change0.00 / 0.00%
  • Shares traded55.10k
  • 1 Year change-47.71%
  • Beta-0.3743
Data delayed at least 15 minutes, as of Jul 05 2024 20:55 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

United Health Products, Inc. develops, manufactures, and markets a hemostatic gauze for the healthcare and wound care sectors. Its gauze product, HemoStyp, is derived from cotton and designed to absorb exudate/drainage from superficial wounds and help control bleeding. HemoStyp hemostatic gauze is a flexible, silk-like material that is applied by placing the gauze onto the bleeding tissue. The supple material can be easily folded and manipulated as needed to fit the size of the wound or incision. In surface bleeding and surgical situations, the product quickly converts to a translucent gel that allows the physician or surgeon to monitor the coagulation process. In superficial bleeding situations, HemoStyp can be bonded to an adhesive plastic bandage or integrated into a traditional gauze component to address a range of needs, including traumatic bleeding injuries and prolonged bleeding following hemodialysis. Its customer base includes hospitals, surgery centers, clinics and others.

  • Revenue in USD (TTM)0.00
  • Net income in USD-1.93m
  • Incorporated1997
  • Employees6.00
  • Location
    United Health Products Inc526 Commerce Circle, Ste. #120MESQUITE 89027United StatesUSA
  • Phone+1 (475) 755-1005
  • Websitehttps://uhpcorp.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
electroCore, Inc.18.69m-16.47m37.54m68.00--8.35--2.01-2.85-2.853.130.74861.161.3054.34274,897.10-102.35-70.73-177.94-88.9682.7075.81-88.12-352.821.18--0.00--86.5774.4215.02---5.88--
Precision Optics Corporation Inc19.41m-1.64m37.81m84.00--3.36--1.95-0.2706-0.27063.241.861.064.304.51231,098.50-8.98-6.71-13.18-10.5533.6533.65-8.43-5.021.05-8.860.1982--34.2339.1284.42--19.39--
BioNano Genomics Inc37.47m-226.79m38.16m344.00--0.3968--1.02-6.15-6.150.9421.440.16651.034.97108,924.40-100.76-56.82-128.31-67.8327.5425.38-605.26-505.761.13-83.420.0444--29.9024.65-75.34--38.51--
BioRegenx Inc634.81k-727.95k38.26m10.00--2.25--60.27-0.001-0.0010.00160.01780.0617----63,481.00-7.07---8.46--74.90---114.67--0.1547-8.800.0977---47.25---629.37------
Lucid Diagnostics Inc2.98m-54.53m39.15m70.00------13.13-1.27-1.270.06980.25440.0735--78.5042,614.29-115.88---248.82---111.06---1,576.63--1.36--0.5579--544.03--6.24------
Co-Diagnostics Inc6.68m-38.89m40.04m155.00--0.5110--6.00-1.32-1.320.22682.510.06561.144.2643,083.48-38.195.77-39.936.1541.3482.24-582.3610.949.90--0.000.00-80.09179.54-148.15--101.27--
Vicarious Surgical Inc0.00-61.15m40.63m131.00--2.04-----11.78-11.780.003.380.00----0.00-54.03---56.98--------------0.00-------1,478.15------
IR-Med Inc0.00-4.22m42.41m6.00---------0.0608-0.06080.00-0.00120.00----0.00-285.64---463.30--------------2.16-------3.70------
United Health Products Inc0.00-1.93m44.01m6.00---------0.008-0.0080.00-0.00730.000.00--0.00-719.43-6,446.86------53.19---132,561.200.0483-15.60-----100.00---55.45------
Modular Medical Inc0.00-17.47m45.55m39.00--3.94-----0.795-0.7950.000.35530.00----0.00-165.97-187.51-187.67-234.72------------0.00-------25.87--85.63--
Vaso Corp80.54m3.18m45.58m300.0012.561.7811.150.5660.02070.02070.45890.14591.1620.037.77268,470.004.577.607.4416.6261.8358.393.955.821.37--0.0091--2.181.84-57.46---22.33--
Envoy Medical Inc297.00k-22.43m45.86m34.00------154.42-2.21-2.210.0194-0.37820.04940.47372.368,735.29-381.38---2,885.46---118.18---7,718.86--0.8969-16.54----33.33---87.83------
Apyx Medical Corp50.45m-22.81m46.42m252.00--2.29--0.9202-0.6583-0.65831.460.58460.79141.774.49200,202.40-35.94-25.24-46.73-29.9763.7066.11-45.41-46.004.94-9.210.6207--17.6125.8219.28--7.99--
Cytosorbents Corp36.69m-27.54m46.70m186.00--2.47--1.27-0.5869-0.58690.77480.34860.70194.825.97197,237.50-52.69-36.00-68.27-43.5264.0868.15-75.07-62.711.21-114.700.1896--4.7910.0613.12---9.24--
Alpha Teknova Inc36.85m-36.06m49.40m210.00--0.5924--1.34-1.05-1.051.052.040.28152.297.89175,490.50-27.54---29.30--27.36---97.85--3.92-28.230.1365---11.43--22.52------
Milestone Scientific Inc9.48m-7.06m50.97m17.00--6.78--5.38-0.0948-0.09480.12650.09740.80250.775612.04557,570.60-60.13-55.48-80.86-74.7269.4263.97-74.93-88.941.80--0.0011--11.600.423320.41---7.99--
Data as of Jul 05 2024. Currency figures normalised to United Health Products Inc's reporting currency: US Dollar USD

Institutional shareholders

0.07%Per cent of shares held by top holders
HolderShares% Held
Slatestone Wealth LLCas of 31 Mar 2024161.91k0.07%
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.